Changes in Body Fat and Related Biochemical Parameters Associated With Atypical Antipsychotic Drug Treatment in Schizophrenia Patients With or Without Metabolic Syndrome

Background: Metabolic syndrome (MetS) is a common problem in schizophrenia patients and associated with increased mortality due to cardiovascular disease. Second-generation antipsychotics (SGAs) play an important role in facilitating MetS.Objective: The study aimed to assess weight changes and alter...

Full description

Bibliographic Details
Main Authors: Elena G. Kornetova, Alexander N. Kornetov, Irina A. Mednova, Viktoria V. Dubrovskaya, Anastasia S. Boiko, Nikolay A. Bokhan, Anton J. M. Loonen, Svetlana A. Ivanova
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-11-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fpsyt.2019.00803/full